GeoVax Recent News

GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update

 
News Release Takeaways
  • Cancer Immunotherapy – Collaborations with University of Pittsburgh and ViaMune, Inc.,Vaxeal Holding SA., Emory University and Leidos, Inc.
  • HIV “Functional Cure” Immunotherapy – We are participating in a planned clinical trialled by researchers at American Gene Technologies (AGT) (www.americangene.com), to develop a therapy aimed at eliminating HIV from infected people.
  • HIV Preventive Vaccine – We are planning for a new Phase 1 human clinical trial with operational support from the HIV Vaccine Trials Network (HVTN) and funding from the National Institute of Allergy and Infectious Diseases (NIAID).  

Authors

GeoVax

SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
Copyright © GeoVax 2022. All Rights Reserved.

Search